Obesity won’t just make you fat, sick and dead — it’ll also leave you crippled, weak and battling constant pain.
Archives for October 2010
Glucosamine under attack
You could do everything right and still get hit with the arthritis monster… and there’s one safe, common and inexpensive supplement millions rely on to get by. So naturally, a few know-it-all “scientists” want to take it right out of your medicine chest.
Toymakers fight new safety regulations
Some toy companies are trying to play cute — they’re declaring that anything that might also be used by an adult isn’t a children’s product, and therefore doesn’t have to meet the new standards.
Youths chow down on junk-food diet
researchers analyzed the “diets” of kids between 2 and 18 years old, and found that the average American child drinks 173 calories a day in sugar-sweetened beverages, gobbles down 138 calories a day in “grain desserts” like cookies and donuts, and devours 136 calories a day in pizza.
Lifestyle changes top diabetes drugs
While diabetes drugs have been linked to everything from heart attack and stroke to cancer, common-sense lifestyle changes can help you take charge of your disease while lowering your risk of just about everything else.
New rules only apply to new patients
If you’ve got one foot in the grave already thanks to Avandia, the feds want to give you a little shove to help finish the job.
Mainstream pushes radiation tests
Hot on the heels of a report urging healthy women to take breast cancer meds even if they have no signs of the disease, the Los Angeles Times issued another stunner — urging people to go out and get their X-rays.
The pink-ribbon campaign’s dirty little secret
Pink ribbons don’t exist to cure disease or save lives — they represent a Big Pharma-funded effort to drive millions of women through a funnel of screenings for a disease many don’t even have, and treatments that most of them don’t even need.
Off-label nausea meds linked to clot risk
A new study shows just what’s on the line when people take dangerous antipsychotic meds: their lives.
Shock treatment making a comeback
The mainstream wants to turn back the clock on depression, with new treatment guidelines backing an oldie that you might not think of as a goodie: shock treatment.

